Featured Now This Is UncomfortableWorkplace CultureBrains and LossesHow We Survive

Loading...

0:00
0% played
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Make Me Smart with Kai and Molly

Bonus: "This Is Uncomfortable," episode 2

Jun 22, 2019
More Info
Share on

Latest Episodes

Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Tech
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
This Is Uncomfortable
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Share
Share on
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

Our Shows

Marketplace Morning Report 4,816 Episodes
Marketplace 3,867 Episodes
Marketplace Tech 2,573 Episodes
Make Me Smart with Kai and Molly 134 Episodes
Corner Office from Marketplace 105 Episodes
The Uncertain Hour 25 Episodes
This Is Uncomfortable 3 Episodes
Stories Tagged as
FDA

Energy drinks may cause serious heart problems, study shows

by Renata Sago May 30, 2019
A combination of ingredients may cause potentially life-threatening electrical malfunctions in the heart.
Jack Taylor/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE

New gene therapy drug expected to hit market with head-spinning price tag

by Kimberly Adams May 22, 2019
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Swiss pharmaceutical giant Novartis' Basel headquarters.
SEBASTIEN BOZON/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Government shutdown 2019

Tech IPOs were set for a comeback, then the government shut down

by Molly Wood Jan 18, 2019
Is the tech IPO resurgence at risk?
Companies like Uber that have filed for IPOs are stalled while the SEC lawyers and accountants who work on IPOs are shut down along with the government.
Adam Berry/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Menthol ban would undo years of marketing to African Americans

by Erika Beras Nov 16, 2018
After World War II, tobacco companies found blacks slightly preferred menthol more than whites; decades of marketing followed.
 Menthol cigarettes are seen for sale on a shelf at a Quick Stop store on March 30, 2010 in Miami, Florida.
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

FDA may seek to regulate menthol and e-cigarettes

by Tracey Samuelson Nov 12, 2018
Regulatory changes would face a process that could take years and face litigation.
 Menthol cigarettes are seen for sale on a shelf at a Quick Stop store on March 30, 2010 in Miami, Florida. 
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

FDA warns e-cigarette manufacturers about teen use

by Justin Ho Sep 12, 2018
They warn the usage of e-cigarettes by teens has reached an epidemic proportion.
Dan Kitwood/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Here's why there's a shortage of EpiPens

by Dan Gorenstein Aug 23, 2018
The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen…
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE

Invest in Marketplace today

Ask not what Marketplace can do for you, but what you can do for Marketplace.

Donate

The FDA approves the first drug derived from cannabis

by Nancy Marshall-Genzer Jun 28, 2018
Will this be the catalyst for big pharmaceutical companies to get into the pot business?
An assistant studies cannabis leaves in the Maripharma Laboratory in Rotterdam, Netherlands, in 2002.
Michel Porro/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

House passes measure giving terminally ill patients more access to experimental drugs

by Amy Scott May 23, 2018
More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called “right-to-try” bill. Forty states have already passed similar legislation.…
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

FDA website to post names of drug makers blocking development of cheaper generics

by Dan Gorenstein May 17, 2018
The FDA plans to unveil a website today naming pharmaceutical companies that have blocked the development of generic drugs by failing to provide samples to competitors. This public posting is part of FDA Commissioner Scott Gottlieb’s larger crackdown to, as…
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE